APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetic Research

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmacokinetic Research Industry Growth and Trends Forecast to 2032

Report ID 17421466013 May 2026110 pages

Choose your research edition.

Industry ResearchPharmacokinetic Research Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetic Research Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacokinetic Research Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetic Research Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetic Research Market Analysis and Forecast 2026-2032241 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmacokinetic Research market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmacokinetic Research market include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences and Allucent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmacokinetic Research market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmacokinetic Research market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmacokinetic Research market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmacokinetic Research.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmacokinetic Research market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmacokinetic Research Market by Company

Eurofins

PPD

LabCorp

Charles River

BioPharma Services

Biotrial

QPS Holdings

Altasciences

Allucent

Admescope

CTI

WuXi AppTec

GenScript

Wuxi Biologics

Medicilon

Pharmaron

Frontage

Shanghai Model

Pharmacokinetic Research Segment by Type

In Vitro and Radioactive ADME

In Vivo PK and PD

New Drugs and New Molecules

Other

Pharmacokinetic Research Segment by Application

Pharmaceutical Industry

Government Agencies and Ministry of Health

Agriculture and Chemical Industry

University

Pharmacokinetic Research Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Research market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Research and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Research.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmacokinetic Research companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetic Research Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmacokinetic Research Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmacokinetic Research Market Share by Region (2021-2026) Table 4. Global Pharmacokinetic Research Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmacokinetic Research Market Share by Region (2027-2032) Table 6. Global Pharmacokinetic Research Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmacokinetic Research Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmacokinetic Research Market Size Share by Type (2021-2026) Table 9. Global Pharmacokinetic Research Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmacokinetic Research Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmacokinetic Research Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmacokinetic Research Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmacokinetic Research Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmacokinetic Research Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmacokinetic Research Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmacokinetic Research Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmacokinetic Research Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmacokinetic Research Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmacokinetic Research Market Size Share by Application (2021-2026) Table 24. Global Pharmacokinetic Research Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmacokinetic Research Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmacokinetic Research Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmacokinetic Research Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmacokinetic Research Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmacokinetic Research Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmacokinetic Research Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmacokinetic Research Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmacokinetic Research Industry Trends Table 37. Pharmacokinetic Research Industry Drivers Table 38. Pharmacokinetic Research Industry Opportunities and Challenges Table 39. Pharmacokinetic Research Industry Restraints Table 40. Global Pharmacokinetic Research Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmacokinetic Research Revenue Market Share by Company (2021-2026) Table 42. Global Pharmacokinetic Research Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmacokinetic Research Key Company Headquarters & Area Served Table 44. Global Pharmacokinetic Research Company, Product Type & Application Table 45. Global Pharmacokinetic Research Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmacokinetic Research by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eurofins Company Information Table 49. Eurofins Business Overview Table 50. Eurofins Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eurofins Pharmacokinetic Research Product Portfolio Table 52. Eurofins Recent Development Table 53. PPD Company Information Table 54. PPD Business Overview Table 55. PPD Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. PPD Pharmacokinetic Research Product Portfolio Table 57. PPD Recent Development Table 58. LabCorp Company Information Table 59. LabCorp Business Overview Table 60. LabCorp Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. LabCorp Pharmacokinetic Research Product Portfolio Table 62. LabCorp Recent Development Table 63. Charles River Company Information Table 64. Charles River Business Overview Table 65. Charles River Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Pharmacokinetic Research Product Portfolio Table 67. Charles River Recent Development Table 68. BioPharma Services Company Information Table 69. BioPharma Services Business Overview Table 70. BioPharma Services Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. BioPharma Services Pharmacokinetic Research Product Portfolio Table 72. BioPharma Services Recent Development Table 73. Biotrial Company Information Table 74. Biotrial Business Overview Table 75. Biotrial Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Biotrial Pharmacokinetic Research Product Portfolio Table 77. Biotrial Recent Development Table 78. QPS Holdings Company Information Table 79. QPS Holdings Business Overview Table 80. QPS Holdings Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. QPS Holdings Pharmacokinetic Research Product Portfolio Table 82. QPS Holdings Recent Development Table 83. Altasciences Company Information Table 84. Altasciences Business Overview Table 85. Altasciences Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Altasciences Pharmacokinetic Research Product Portfolio Table 87. Altasciences Recent Development Table 88. Allucent Company Information Table 89. Allucent Business Overview Table 90. Allucent Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Allucent Pharmacokinetic Research Product Portfolio Table 92. Allucent Recent Development Table 93. Admescope Company Information Table 94. Admescope Business Overview Table 95. Admescope Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Admescope Pharmacokinetic Research Product Portfolio Table 97. Admescope Recent Development Table 98. CTI Company Information Table 99. CTI Business Overview Table 100. CTI Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CTI Pharmacokinetic Research Product Portfolio Table 102. CTI Recent Development Table 103. WuXi AppTec Company Information Table 104. WuXi AppTec Business Overview Table 105. WuXi AppTec Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. WuXi AppTec Pharmacokinetic Research Product Portfolio Table 107. WuXi AppTec Recent Development Table 108. GenScript Company Information Table 109. GenScript Business Overview Table 110. GenScript Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. GenScript Pharmacokinetic Research Product Portfolio Table 112. GenScript Recent Development Table 113. Wuxi Biologics Company Information Table 114. Wuxi Biologics Business Overview Table 115. Wuxi Biologics Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Wuxi Biologics Pharmacokinetic Research Product Portfolio Table 117. Wuxi Biologics Recent Development Table 118. Medicilon Company Information Table 119. Medicilon Business Overview Table 120. Medicilon Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Medicilon Pharmacokinetic Research Product Portfolio Table 122. Medicilon Recent Development Table 123. Pharmaron Company Information Table 124. Pharmaron Business Overview Table 125. Pharmaron Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Pharmaron Pharmacokinetic Research Product Portfolio Table 127. Pharmaron Recent Development Table 128. Frontage Company Information Table 129. Frontage Business Overview Table 130. Frontage Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Frontage Pharmacokinetic Research Product Portfolio Table 132. Frontage Recent Development Table 133. Shanghai Model Company Information Table 134. Shanghai Model Business Overview Table 135. Shanghai Model Pharmacokinetic Research Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Shanghai Model Pharmacokinetic Research Product Portfolio Table 137. Shanghai Model Recent Development Table 138. North America Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Pharmacokinetic Research Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Pharmacokinetic Research Market Share by Country (2021-2026) Table 141. North America Pharmacokinetic Research Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Pharmacokinetic Research Market Share Forecast by Country (2027-2032) Table 143. Europe Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Pharmacokinetic Research Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Pharmacokinetic Research Market Share by Country (2021-2026) Table 146. Europe Pharmacokinetic Research Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Pharmacokinetic Research Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Pharmacokinetic Research Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Pharmacokinetic Research Market Share by Country (2021-2026) Table 151. Asia-Pacific Pharmacokinetic Research Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Pharmacokinetic Research Market Share Forecast by Country (2027-2032) Table 153. Latin America Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Pharmacokinetic Research Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Pharmacokinetic Research Market Share by Country (2021-2026) Table 156. Latin America Pharmacokinetic Research Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Pharmacokinetic Research Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Pharmacokinetic Research Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Pharmacokinetic Research Market Share by Country (2021-2026) Table 161. Middle East & Africa Pharmacokinetic Research Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Pharmacokinetic Research Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmacokinetic Research Product Image Figure 3. Global Pharmacokinetic Research Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmacokinetic Research Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmacokinetic Research Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmacokinetic Research Market Share by Region (2021-2032) Figure 7. North America Pharmacokinetic Research Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmacokinetic Research Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmacokinetic Research Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmacokinetic Research Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmacokinetic Research Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. In Vitro and Radioactive ADME Image Figure 13. Global In Vitro and Radioactive ADME Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. In Vivo PK and PD Image Figure 15. Global In Vivo PK and PD Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. New Drugs and New Molecules Image Figure 17. Global New Drugs and New Molecules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Pharmacokinetic Research Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Pharmacokinetic Research Market Share by Type 2025 VS 2032 Figure 22. North America Pharmacokinetic Research Market Size Share by Type (2021-2032) Figure 23. Europe Pharmacokinetic Research Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Pharmacokinetic Research Market Size Share by Type (2021-2032) Figure 25. Latin America Pharmacokinetic Research Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Pharmacokinetic Research Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Industry Image Figure 28. Global Pharmaceutical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Government Agencies and Ministry of Health Image Figure 30. Global Government Agencies and Ministry of Health Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Agriculture and Chemical Industry Image Figure 32. Global Agriculture and Chemical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. University Image Figure 34. Global University Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Pharmacokinetic Research Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pharmacokinetic Research Market Share by Application 2025 VS 2032 Figure 37. North America Pharmacokinetic Research Market Size Share by Application (2021-2032) Figure 38. Europe Pharmacokinetic Research Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Pharmacokinetic Research Market Size Share by Application (2021-2032) Figure 40. Latin America Pharmacokinetic Research Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Pharmacokinetic Research Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Pharmacokinetic Research Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Pharmacokinetic Research Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Pharmacokinetic Research Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Pharmacokinetic Research Market Share by Country (2021-2032) Figure 47. Europe Pharmacokinetic Research Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pharmacokinetic Research Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharmacokinetic Research Market Share by Country (2021-2032) Figure 50. Asia-Pacific Pharmacokinetic Research Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Pharmacokinetic Research Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Pharmacokinetic Research Market Share by Country (2021-2032) Figure 53. Latin America Pharmacokinetic Research Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Pharmacokinetic Research Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharmacokinetic Research Market Share by Country (2021-2032) Figure 56. Middle East & Africa Pharmacokinetic Research Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Pharmacokinetic Research Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Pharmacokinetic Research Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other
Applications
  • Pharmaceutical Industry
  • Government Agencies and Ministry of Health
  • Agriculture and Chemical Industry
  • University
Companies covered
  • Eurofins
  • PPD
  • LabCorp
  • Charles River
  • BioPharma Services
  • Biotrial
  • QPS Holdings
  • Altasciences
  • Allucent
  • Admescope
  • CTI
  • WuXi AppTec
  • GenScript
  • Wuxi Biologics
  • Medicilon
  • Pharmaron
  • Frontage
  • Shanghai Model

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmacokinetic Research Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmacokinetic Research Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmacokinetic Research Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmacokinetic Research Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmacokinetic Research Market Size (2021-2032)
  8. 1.5.1 North America Pharmacokinetic Research Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmacokinetic Research Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmacokinetic Research Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmacokinetic Research Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmacokinetic Research Market Size Growth Rate (2021-2032)
2 Pharmacokinetic Research Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 In Vitro and Radioactive ADME
  3. 2.1.2 In Vivo PK and PD
  4. 2.1.3 New Drugs and New Molecules
  5. 2.1.4 Other
  6. 2.2 Global Pharmacokinetic Research Market Size by Type
  7. 2.2.1 Global Pharmacokinetic Research Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Pharmacokinetic Research Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Pharmacokinetic Research Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Pharmacokinetic Research Market Size by Regions
  11. 2.3.1 North America Pharmacokinetic Research Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Pharmacokinetic Research Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Pharmacokinetic Research Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Type (2021-2026)
3 Pharmacokinetic Research Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Industry
  3. 3.1.2 Government Agencies and Ministry of Health
  4. 3.1.3 Agriculture and Chemical Industry
  5. 3.1.4 University
  6. 3.2 Global Pharmacokinetic Research Market Size by Application
  7. 3.2.1 Global Pharmacokinetic Research Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Pharmacokinetic Research Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Pharmacokinetic Research Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Pharmacokinetic Research Market Size by Regions
  11. 3.3.1 North America Pharmacokinetic Research Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Pharmacokinetic Research Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Pharmacokinetic Research Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Pharmacokinetic Research Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Pharmacokinetic Research Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmacokinetic Research Industry Trends
  2. 4.2 Pharmacokinetic Research Industry Drivers
  3. 4.3 Pharmacokinetic Research Industry Opportunities and Challenges
  4. 4.4 Pharmacokinetic Research Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmacokinetic Research Revenue (2021-2026)
  2. 5.2 Global Pharmacokinetic Research Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmacokinetic Research Key Company Headquarters & Area Served
  4. 5.4 Global Pharmacokinetic Research Company, Product Type & Application
  5. 5.5 Global Pharmacokinetic Research Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmacokinetic Research Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmacokinetic Research Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmacokinetic Research Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eurofins
  2. 6.1.1 Eurofins Company Information
  3. 6.1.2 Eurofins Business Overview
  4. 6.1.3 Eurofins Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eurofins Pharmacokinetic Research Product Portfolio
  6. 6.1.5 Eurofins Recent Developments
  7. 6.2 PPD
  8. 6.2.1 PPD Company Information
  9. 6.2.2 PPD Business Overview
  10. 6.2.3 PPD Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 PPD Pharmacokinetic Research Product Portfolio
  12. 6.2.5 PPD Recent Developments
  13. 6.3 LabCorp
  14. 6.3.1 LabCorp Company Information
  15. 6.3.2 LabCorp Business Overview
  16. 6.3.3 LabCorp Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 LabCorp Pharmacokinetic Research Product Portfolio
  18. 6.3.5 LabCorp Recent Developments
  19. 6.4 Charles River
  20. 6.4.1 Charles River Company Information
  21. 6.4.2 Charles River Business Overview
  22. 6.4.3 Charles River Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Pharmacokinetic Research Product Portfolio
  24. 6.4.5 Charles River Recent Developments
  25. 6.5 BioPharma Services
  26. 6.5.1 BioPharma Services Company Information
  27. 6.5.2 BioPharma Services Business Overview
  28. 6.5.3 BioPharma Services Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 BioPharma Services Pharmacokinetic Research Product Portfolio
  30. 6.5.5 BioPharma Services Recent Developments
  31. 6.6 Biotrial
  32. 6.6.1 Biotrial Company Information
  33. 6.6.2 Biotrial Business Overview
  34. 6.6.3 Biotrial Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Biotrial Pharmacokinetic Research Product Portfolio
  36. 6.6.5 Biotrial Recent Developments
  37. 6.7 QPS Holdings
  38. 6.7.1 QPS Holdings Company Information
  39. 6.7.2 QPS Holdings Business Overview
  40. 6.7.3 QPS Holdings Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 QPS Holdings Pharmacokinetic Research Product Portfolio
  42. 6.7.5 QPS Holdings Recent Developments
  43. 6.8 Altasciences
  44. 6.8.1 Altasciences Company Information
  45. 6.8.2 Altasciences Business Overview
  46. 6.8.3 Altasciences Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Altasciences Pharmacokinetic Research Product Portfolio
  48. 6.8.5 Altasciences Recent Developments
  49. 6.9 Allucent
  50. 6.9.1 Allucent Company Information
  51. 6.9.2 Allucent Business Overview
  52. 6.9.3 Allucent Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Allucent Pharmacokinetic Research Product Portfolio
  54. 6.9.5 Allucent Recent Developments
  55. 6.10 Admescope
  56. 6.10.1 Admescope Company Information
  57. 6.10.2 Admescope Business Overview
  58. 6.10.3 Admescope Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Admescope Pharmacokinetic Research Product Portfolio
  60. 6.10.5 Admescope Recent Developments
  61. 6.11 CTI
  62. 6.11.1 CTI Company Information
  63. 6.11.2 CTI Business Overview
  64. 6.11.3 CTI Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CTI Pharmacokinetic Research Product Portfolio
  66. 6.11.5 CTI Recent Developments
  67. 6.12 WuXi AppTec
  68. 6.12.1 WuXi AppTec Company Information
  69. 6.12.2 WuXi AppTec Business Overview
  70. 6.12.3 WuXi AppTec Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 WuXi AppTec Pharmacokinetic Research Product Portfolio
  72. 6.12.5 WuXi AppTec Recent Developments
  73. 6.13 GenScript
  74. 6.13.1 GenScript Company Information
  75. 6.13.2 GenScript Business Overview
  76. 6.13.3 GenScript Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 GenScript Pharmacokinetic Research Product Portfolio
  78. 6.13.5 GenScript Recent Developments
  79. 6.14 Wuxi Biologics
  80. 6.14.1 Wuxi Biologics Company Information
  81. 6.14.2 Wuxi Biologics Business Overview
  82. 6.14.3 Wuxi Biologics Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Wuxi Biologics Pharmacokinetic Research Product Portfolio
  84. 6.14.5 Wuxi Biologics Recent Developments
  85. 6.15 Medicilon
  86. 6.15.1 Medicilon Company Information
  87. 6.15.2 Medicilon Business Overview
  88. 6.15.3 Medicilon Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Medicilon Pharmacokinetic Research Product Portfolio
  90. 6.15.5 Medicilon Recent Developments
  91. 6.16 Pharmaron
  92. 6.16.1 Pharmaron Company Information
  93. 6.16.2 Pharmaron Business Overview
  94. 6.16.3 Pharmaron Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Pharmaron Pharmacokinetic Research Product Portfolio
  96. 6.16.5 Pharmaron Recent Developments
  97. 6.17 Frontage
  98. 6.17.1 Frontage Company Information
  99. 6.17.2 Frontage Business Overview
  100. 6.17.3 Frontage Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Frontage Pharmacokinetic Research Product Portfolio
  102. 6.17.5 Frontage Recent Developments
  103. 6.18 Shanghai Model
  104. 6.18.1 Shanghai Model Company Information
  105. 6.18.2 Shanghai Model Business Overview
  106. 6.18.3 Shanghai Model Pharmacokinetic Research Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Shanghai Model Pharmacokinetic Research Product Portfolio
  108. 6.18.5 Shanghai Model Recent Developments
7 North America
  1. 7.1 North America Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmacokinetic Research Market Size by Country (2021-2026)
  3. 7.3 North America Pharmacokinetic Research Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmacokinetic Research Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmacokinetic Research Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmacokinetic Research Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmacokinetic Research Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmacokinetic Research Market Size by Country (2021-2026)
  3. 10.3 South America Pharmacokinetic Research Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmacokinetic Research Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmacokinetic Research Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmacokinetic Research Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst